KM

Kromek Group PLC (KMK)

TechnologyScientific & Technical Instruments
10.25GBX
+0.00%
Magic Rank
#188
Earnings Yield
11.5%
Return on Capital
40.7%
Market Cap
42.6M

Performance vs S&P 500 (5Y)

KMK.LSE
S&P 500

About Kromek Group PLC

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems. In addition, it offers products and components for the security and defence markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples. Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, and internationally. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.

Magic Formula Analysis

Enterprise Value41.3M
Market / Universe
gb
United Kingdom

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio6.50
Dividend YieldN/A
Debt to Equity-0.03
Gross Margin41.7%